Transient Elastography–Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United States
- 1 April 2022
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 20 (4) , e808-e830
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (HHSN275201700074U)
This publication has 23 references indexed in Scilit:
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver diseaseHepatology, 2017
- Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver BiopsyDigestive Diseases and Sciences, 2017
- Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology, 2016
- The Epidemiology of Cirrhosis in the United StatesJournal of Clinical Gastroenterology, 2015
- Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam studyHepatology, 2015
- Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populationsWorld Journal of Hepatology, 2014
- The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®Clinics and Research in Hepatology and Gastroenterology, 2012
- Trunk Fat Is Associated With Increased Serum Levels of Alanine Aminotransferase in the United StatesGastroenterology, 2010
- Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studiesBMJ, 2010